AstronauTx
Biotech · London, GB
Biotech developing small-molecule treatments for Alzheimer's and neurodegenerative disease.
Funding history
| Date | Round | Amount |
|---|
| Oct 2023 | Series A UK biotech AstronauTx raised a £48M Series A led by Novartis Venture Fund to advance Alzheimer's treatments. | $60M |
Investors
Brandon CapitalBristol Myers SquibbEQT Life SciencesNovartis Venture Fund
Similar companies in Biotech
Explore funding flow on EquityFlow →